Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome

The Journal of Clinical Investigation
A S Lau, J F Livesey

Abstract

High levels of an acid-labile IFN-alpha have been demonstrated in the sera of patients with symptomatic HIV infection. IFNs have been shown to enhance the cytotoxic and antiproliferative actions of tumor necrosis factor (TNF), which is a potent mediator of inflammation and sepsis. We show that the acid-labile IFN-alpha present in AIDS sera can induce TNF synthesis and sensitize blood monocytes (BM) to endotoxin stimulation resulting in further synthesis of TNF in vitro. TNF production by BM from patients with HIV infections and normal controls was measured by a cytotoxicity assay on L929 cells using human TNF alpha as a standard. BM from AIDS patients spontaneously produce high levels of TNF and are hypersensitive to endotoxin stimulation, resulting in enhanced synthesis of TNF. In determining the mechanism involved, we demonstrated that treatment of normal BM with AIDS sera results in induction of TNF. Neutralization of the acid-labile IFN-alpha in AIDS sera with polyclonal anti-IFN-alpha antibodies results in diminution of TNF induction. In addition, pretreatment of normal BM with AIDS sera, IFN-alpha, or IFN-gamma renders the cells hypersensitive to endotoxin. Consequently, activation of the TNF system by the acid-labile IFN...Continue Reading

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Feb 1, 1985·The Journal of Pediatrics·K M Shannon, A J Ammann
Jun 30, 1986·Biochemical and Biophysical Research Communications·M TsujimotoG Weissmann
Jan 1, 1988·Immunology Today·A Cerami, B Beutler
Feb 12, 1987·The New England Journal of Medicine·B Beutler, A Cerami
Mar 1, 1986·The Journal of Experimental Medicine·P P Nawroth, D M Stern
Oct 24, 1986·Science·K J TraceyJ D Albert
Jan 28, 1985·FEBS Letters·S AbeD Mizuno
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B D WilliamsonL J Old
Mar 1, 1984·The Journal of Experimental Medicine·D S Stone-WolffJ Vilcek
Oct 1, 1982·The Journal of Infectious Diseases·E DeStefanoJ Vilcek

❮ Previous
Next ❯

Citations

Nov 1, 1995·Medicinal Research Reviews·J Pallarés-TrujilloJ M Argilés
Nov 1, 1992·Digestive Diseases and Sciences·D R MackP M Sherman
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·D F DarkoM M Mitler
Apr 29, 2000·Journal of Women's Health & Gender-based Medicine·B J Lane, M A Provost-Craig
Jun 1, 1991·AIDS Research and Human Retroviruses·A S LauB R Williams
Aug 1, 1991·AIDS Research and Human Retroviruses·H X GanJ W Mellors
Mar 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M K HellersteinR A Neese
Jun 1, 1991·Metabolism: Clinical and Experimental·M J HommesH P Sauerwein
Mar 1, 1995·Baillière's Clinical Haematology·V F La Russa, B L Innis
Apr 1, 1991·The American Journal of Medicine·A SchattnerT Hahn
Nov 1, 1991·Cytokine·W L FarrarK A Clouse
Jan 1, 1995·Advances in Neuroimmunology·D F DarkoS J Henriksen
Sep 1, 1992·Clinical and Experimental Immunology·A KalinkovichZ Bentwich
Jan 1, 1992·International Journal of STD & AIDS·J Main, J Handley
Aug 1, 1993·Nutrition Reviews·S L GorbachR Roubenoff
Feb 1, 1991·Clinical and Experimental Immunology·D P DooleyD J Looney
Sep 1, 1991·Medical Hypotheses·J FuchsH Rübsamen-Waigmann
Dec 1, 1989·The Journal of Pediatrics·B A LangA S Lau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.